FULC
NASDAQ · Pharmaceuticals
Fulcrum Therapeutics Inc
$3.76
-0.01 (-0.27%)
Open$3.77
Previous Close$3.77
Day High$3.81
Day Low$3.76
52W High$15.74
52W Low$2.83
Volume—
Avg Volume1.11M
Market Cap287.64M
P/E Ratio—
EPS$-0.90
SectorPharmaceuticals
Analyst Ratings
Sell
11 analysts
Price Target
+1,415.4% upside
Current
$3.76
$3.76
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 88.39M | 54.89M | 366.88M |
| Net Income | -10,744,616 | -6,005,188 | 47.13M |
| Profit Margin | -12.2% | -11.6% | 12.9% |
| EBITDA | -8,984,663 | -5,300,521 | 69.95M |
| Free Cash Flow | — | — | 54.75M |
| Rev Growth | +61.0% | +61.0% | +22.0% |
| Debt/Equity | — | — | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |